Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. 24 HRS URINE PROTEIN

If you miss a sample, it is crucial to contact the hospital for guidance. You may need to start the collection period again to ensure accurate results.

Most medications can be taken as usual, but it’s important to inform your healthcare provider about any medications or supplements you are using.

It’s essential to collect all urine during the 24-hour period. If you experience a spill or loss, contact the hospital to determine the best course of action.

The collected urine should be kept refrigerated throughout the collection period to preserve its integrity.

Results are typically available within 1 to 3 days after the sample is submitted to the laboratory. Your healthcare provider will review the results with you and discuss any necessary follow-up steps.

2. Are cochlear implants effective for all types of hearing loss?

Cochlear implants are most effective for individuals with severe to profound sensorineural hearing loss. They may not be suitable for all types of hearing loss or for those with certain medical conditions.

3. HBV DNA VIRAL LOAD

The HBV DNA Viral Load Test measures the amount of Hepatitis B virus DNA in the blood, indicating the level of viral replication and infection severity.

The test is used to confirm active Hepatitis B infection, assess disease severity, monitor treatment response, and guide treatment decisions.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.

Results are usually available within 2 to 4 days after the test.

A high viral load indicates a higher quantity of Hepatitis B virus in the blood, suggesting more active infection and potentially greater disease severity.